We treat one craving as a disease and the other as a weakness. The brain draws no such line.

Give a person a drug for diabetes and watch what happens on the way to lower blood sugar. The urge to drink quiets down. So does the urge to smoke. For some, so does the pull toward opioids or cocaine. In a 2026 study of more than six hundred thousand veterans, people on the GLP-1 drugs, the Ozempic family, showed lower rates of new opioid, alcohol, cocaine, and nicotine problems, all at once. One medicine, built to shrink the appetite for food, shrinks the appetite for nearly everything.

It is not magic. These drugs reach into the reward system, among other places. That is the circuitry that decides what is worth wanting, and it was never built to keep food in one drawer and drugs in another. Nora Volkow, who runs the country's main addiction research agency, and her colleagues have spent two decades showing that overeating and addiction lean on overlapping reward circuitry, the dopamine pathways that drive craving and the brakes we call self-control that give way in both. The hunger that empties a refrigerator at midnight and the craving that empties a bank account are, under the skull, closer to one event than we have ever wanted to admit.

The veteran study cannot prove the drugs caused any of it. It compared them against another diabetes medicine and tracked what followed, and the only randomized trials so far are small, the largest about two hundred and fifty people over twelve weeks. The breadth of it, one drug touching many different cravings, is the kind of pattern you would expect if a single system sat beneath them all. It is also the kind you would expect if the people who end up on these drugs simply differ from those who do not, and a study like this cannot tell which. A hint, then, not a proof. The drug does not know which craving you came to it for.

Which forces the thing we keep dodging. We treat these two compulsions as different kinds of human problem. Addiction, after years of work, we have agreed to call a disease. The National Institute on Drug Abuse calls it a chronic brain disorder, something that happens to a person the way heart disease does. Compulsive eating we still treat as a verdict on character. The same culture that pities the addict tells the person who cannot stop eating that they are lazy and weak, and the research shows their own doctors are not immune to it. One craving earns a clinic and our sympathy. The other earns a diet and our contempt. The brain that makes them never sorted one from the other the way we do. The sorting is ours:

We ration our compassion by appetite.

That is not just unfair. It is incoherent, and the incoherence lands hardest on the people caught in both, because the wiring that pulls toward a drink often pulls toward a binge. They arrive at two systems of care that grew up separately and barely speak. One, built for addiction, may tell them the path is abstinence and control, to name their trigger foods and avoid them. The other, built for eating disorders, may tell them the opposite, that treating food as a drug to be quit is how restriction starts and how the disorder digs in. Both cannot be right for the same person, who is left to referee.

I have a stake to declare. I helped write a review of one of those shared levers in the brain, a receptor that sits among the reward circuits and, in animals, appears to influence the pull toward both drugs and food. The work is early, nothing you can take, and my colleagues and my mentor hold patents in the area, though I do not. Which is its own reason to be skeptical of me. The moment a shared mechanism looks like it might be drugged, everyone who works on it has a reason to play it up, and I am no exception.

So weigh the fight now underway over whether to write "food addiction" into the manuals doctors diagnose from. Part of it is real science. Whether a Pop-Tart hooks the brain the way nicotine does is genuinely unsettled, and researchers argue, with evidence, that it does not. The clinicians who fear that calling food addictive will drive vulnerable patients back into starvation are naming a real danger, not protecting turf. But underneath the honest disagreement runs a less honest one, a fight over who to blame: the eater, or the industry that engineers the food to be overeaten. We are litigating the label while the underlying overlap in reward circuitry has been mainstream science for years.

The honest position is not that food is a drug, or that addiction is a choice. It is simpler and harder than either. The reward system does not sort our compulsions into the respectable and the shameful, and neither should our medicine or our mercy. You can believe that the science of "food addiction" is unproven, and still see there is no defensible reason to hand one person a disease and the other a character flaw when the same circuitry betrayed them both.

The drugs are about to make this impossible to ignore. As the same medicine is tested on the person with diabetes, then the heavy drinker, then the person who cannot stop eating, the wall between sick and weak will look more like what it is, a line we drew for our own comfort, not one the brain ever recognized. We can keep deciding who deserves help by which appetite undid them. Or we can admit that wanting, when it turns on a person, is one problem, and begin to treat it as one.